يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Complement System Proteins metabolism"', وقت الاستعلام: 1.24s تنقيح النتائج
  1. 1

    المصدر: Frontiers in Immunology, Vol 12 (2021)
    Frontiers in Immunology

    وصف الملف: application/pdf

  2. 2

    المساهمون: Universitat de Barcelona, Rheumatology, AII - Inflammatory diseases, Translational Immunology Groningen (TRIGR)

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    Recercat. Dipósit de la Recerca de Catalunya
    instname
    Annals of the Rheumatic Diseases, 76(3), 554-561. BMJ Publishing Group
    van Vollenhoven, R, Voskuyl, A, Bertsias, G, Aranow, C, Aringer, M, Arnaud, L, Askanase, A, Balážová, P, Bonfa, E, Bootsma, H, Boumpas, D, Bruce, I, Cervera, R, Clarke, A, Coney, C, Costedoat-Chalumeau, N, Czirják, L, Derksen, R, Doria, A, Dörner, T, Fischer-Betz, R, Fritsch-Stork, R, Gordon, C, Graninger, W, Györi, N, Houssiau, F, Isenberg, D, Jacobsen, S, Jayne, D, Kuhn, A, Le Guern, V, Lerstrøm, K, Levy, R, Machado-Ribeiro, F, Mariette, X, Missaykeh, J, Morand, E, Mosca, M, Inanc, M, Navarra, S, Neumann, I, Olesinska, M, Petri, M, Rahman, A, Rekvig, O P, Rovensky, J, Shoenfeld, Y, Smolen, J, Tincani, A, Urowitz, M, van Leeuw, B, Vasconcelos, C, Voss, A, Werth, V P, Zakharova, H, Zoma, A, Schneider, M & Ward, M 2017, ' A framework for remission in SLE : consensus findings from a large international task force on definitions of remission in SLE (DORIS) ', Annals of the Rheumatic Diseases, vol. 76, no. 3, pp. 554-561 . https://doi.org/10.1136/annrheumdis-2016-209519
    Van Vollenhoven, R, Voskuyl, A, Bertsias, G, Aranow, C, Aringer, M, Arnaud, L, Askanase, A, Balážová, P, Bonfa, E, Bootsma, H, Boumpas, D, Bruce, I, Cervera, R, Clarke, A, Coney, C, Costedoat-Chalumeau, N, Czirják, L, Derksen, R, Doria, A, Dörner, T, Fischer-Betz, R, Fritsch-Stork, R, Gordon, C, Graninger, W, Györi, N, Houssiau, F, Isenberg, D, Jacobsen, S, Jayne, D, Kuhn, A, Le Guern, V, Lerstrøm, K, Levy, R, MacHado-Ribeiro, F, Mariette, X, Missaykeh, J, Morand, E, Mosca, M, Inanc, M, Navarra, S, Neumann, I, Olesinska, M, Petri, M, Rahman, A, Rekvig, O P, Rovensky, J, Shoenfeld, Y, Smolen, J, Tincani, A, Urowitz, M, Van Leeuw, B, Vasconcelos, C, Voss, A, Werth, V P, Zakharova, H, Zoma, A, Schneider, M & Ward, M 2017, ' A framework for remission in SLE : Consensus findings from a large international task force on definitions of remission in SLE (DORIS) ', Annals of the Rheumatic Diseases, vol. 76, no. 3, pp. 554-561 . https://doi.org/10.1136/annrheumdis-2016-209519
    Van Vollenhoven, R, Voskuyl, A, Bertsias, G, Aranow, C, Aringer, M, Arnaud, L, Askanase, A, Balážová, P, Bonfa, E, Bootsma, H, Boumpas, D, Bruce, I, Cervera, R, Clarke, A, Coney, C, Costedoat-Chalumeau, N, Czirják, L, Derksen, R, Doria, A, Dörner, T, Fischer-Betz, R, Fritsch-Stork, R, Gordon, C, Graninger, W, Györi, N, Houssiau, F, Isenberg, D, Jacobsen, S, Jayne, D, Kuhn, A, Le Guern, V, Lerstrøm, K, Levy, R, MacHado-Ribeiro, F, Mariette, X, Missaykeh, J, Morand, E, Mosca, M, Inanc, M, Navarra, S, Neumann, I, Olesinska, M, Petri, M, Rahman, A, Rekvig, O P, Rovensky, J, Shoenfeld, Y, Smolen, J, Tincani, A & Urowitz, M 2017, ' A framework for remission in SLE : Consensus findings from a large international task force on definitions of remission in SLE (DORIS) ', Annals of the rheumatic diseases, vol. 76, no. 3, pp. 554-561 . https://doi.org/10.1136/annrheumdis-2016-209519
    Annals of the Rheumatic Diseases, 76(3), 554-561. BMJ PUBLISHING GROUP

    مصطلحات موضوعية: Genetics and Molecular Biology (all), Pediatrics, Autoimmune diseases, NEPHRITIS PATIENTS, DISEASE-ACTIVITY, Severity of Illness Index, Biochemistry, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Quality of life, Prednisone, Adrenal Cortex Hormones, Lupus Erythematosus, Systemic, Immunology and Allergy, CHINESE PATIENTS, 030212 general & internal medicine, SYSTEMIC-LUPUS-ERYTHEMATOSUS, skin and connective tissue diseases, PREDICTORS, OUTCOMES, Systemic lupus erythematosus, Malalties autoimmunitàries, Remission Induction, INITIAL VALIDATION, AMERICAN-COLLEGE, RENAL FLARES, Symptom Flare Up, Connective tissue disease, Manchester Institute for Collaborative Research on Ageing, Estudi de casos, Outcomes research, Antibodies, Antinuclear, DNA/immunology, Immunosuppressive Agents, medicine.drug, medicine.medical_specialty, Farmacologia, ResearchInstitutes_Networks_Beacons/MICRA, Consensus, Immunology, Adrenal Cortex Hormones/therapeutic use, Lupus Erythematosus, Systemic/blood, Systemic Lupus Erythematosus, General Biochemistry, Genetics and Molecular Biology, Maintenance Chemotherapy, 03 medical and health sciences, Antimalarials, Rheumatology, Severity of illness, medicine, Disease Activity, Biochemistry, Genetics and Molecular Biology (all), Humans, 030203 arthritis & rheumatology, Pharmacology, Antibodies, Antinuclear/blood, Lupus erythematosus, business.industry, Task force, Construct validity, Complement System Proteins, DNA, medicine.disease, Lupus eritematós, Antimalarials/therapeutic use, Physical therapy, Immunosuppressive Agents/therapeutic use, Complement System Proteins/metabolism, Case studies, business

    وصف الملف: application/pdf

  3. 3
  4. 4

    المصدر: TRANSPLANTATION
    Transplantation, Vol. 96, No 9 (2013) pp. 791-9
    Transplantation

  5. 5

    المساهمون: BMC, BMC, Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Pathology [Melbourne, Australie], University of Melbourne-Bio21 Molecular Science & Biotechnology Institute [Melbourne] (School of Chemistry), Faculty of Science [Melbourne], University of Melbourne-University of Melbourne-Faculty of Science [Melbourne], University of Melbourne, Equipe Biophysique Neurosensorielle [Neuro-Dol], Neuro-Dol (Neuro-Dol), Université d'Auvergne - Clermont-Ferrand I (UdA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Unit of Gene Therapy & Stem Cell Biology [Lausanne, Suisse], Université de Lausanne = University of Lausanne (UNIL)-Fondation Asile des aveugles - Hôpital Ophtalmique Jules-Gonin [Lausanne], This work was supported by the National Health and Medical Research Council(NHMRC) to RC., Centre de Recherche des Cordeliers (CRC), Université Paris Diderot - Paris 7 (UP7) - École pratique des hautes études (EPHE) - Université Paris Descartes - Paris 5 (UPD5) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Université Pierre et Marie Curie - Paris 6 (UPMC), Bio21 Institute [Melbourne, Australie], Laboratoire de Biophysique Sensorielle, Université d'Auvergne - Clermont-Ferrand I, Unit of Gene Therapy & Stem Cell Biology, University of Lausanne, Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), University of Melbourne-Bio21 Institute [Melbourne, Australie], Neuro-Dol ( Neuro-Dol ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université d'Auvergne - Clermont-Ferrand I ( UdA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université d'Auvergne - Clermont-Ferrand I ( UdA ) -Neuro-Dol - Clermont Auvergne ( Neuro-Dol ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Clermont Auvergne ( UCA ) -Université Clermont Auvergne ( UCA ), Université de Lausanne - UML [Suisse]-Fondation Asile des aveugles - Hôpital Ophtalmique Jules-Gonin [Lausanne, Suisse], Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Neuro-Dol (Neuro-Dol), Université d'Auvergne - Clermont-Ferrand I (UdA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université d'Auvergne - Clermont-Ferrand I (UdA), Université de Lausanne (UNIL)-Fondation Asile des aveugles - Hôpital Ophtalmique Jules-Gonin [Lausanne]

    المصدر: Molecular Brain
    Molecular Brain, 2015, 9 (1), pp.64. ⟨10.1186/s13041-016-0245-z⟩
    Molecular Brain, BioMed Central, 2016, <10.1186/s13041-016-0245-z>
    Molecular Brain, 2015, 9 (1), pp.64. 〈10.1186/s13041-016-0245-z〉
    Molecular brain, vol. 9, no. 1, pp. 64

    مصطلحات موضوعية: 0301 basic medicine, Retinal degeneration, Aging, genetic structures, Transcription, Genetic, [SDV]Life Sciences [q-bio], Ribbon synapse, Synaptic Transmission, chemistry.chemical_compound, Amyloid beta-Protein Precursor, Night Blindness, Amyloid precursor protein, Myopia, Congenital stationary night blindness, Mice, Knockout, biology, Cell Differentiation, Eye Diseases, Hereditary, Genetic Diseases, X-Linked, [SDV] Life Sciences [q-bio], medicine.anatomical_structure, Synaptopathy, Differentiation, Aging/pathology, Amacrine Cells/metabolism, Amyloid beta-Protein Precursor/chemistry, Amyloid beta-Protein Precursor/deficiency, Amyloid beta-Protein Precursor/genetics, Amyloid beta-Protein Precursor/metabolism, Animals, Animals, Newborn, Complement System Proteins/metabolism, Dendrites/metabolism, Eye Diseases, Hereditary/genetics, Eye Diseases, Hereditary/pathology, Eye Diseases, Hereditary/physiopathology, Gene Deletion, Genetic Diseases, X-Linked/genetics, Genetic Diseases, X-Linked/pathology, Genetic Diseases, X-Linked/physiopathology, Mice, Inbred C57BL, Myopia/genetics, Myopia/pathology, Myopia/physiopathology, Neurogenesis, Night Blindness/genetics, Night Blindness/pathology, Night Blindness/physiopathology, Photoreceptor Cells, Vertebrate/metabolism, Photoreceptor Cells, Vertebrate/pathology, Photoreceptor Cells, Vertebrate/ultrastructure, Presynaptic Terminals/metabolism, Presynaptic Terminals/ultrastructure, RNA, Messenger/genetics, RNA, Messenger/metabolism, Retinal Bipolar Cells/metabolism, Retinal Bipolar Cells/pathology, Retinal Bipolar Cells/ultrastructure, Transcription Factors/metabolism, Amyloid precursor-like protein 2, Synapses, Transcription, Photoreceptor Cells, Vertebrate, Retinal Bipolar Cells, Presynaptic Terminals, 03 medical and health sciences, Cellular and Molecular Neuroscience, Night vision, medicine, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, RNA, Messenger, Molecular Biology, Retina, [ SDV ] Life Sciences [q-bio], Research, Retinal, Complement System Proteins, Dendrites, Inner plexiform layer, medicine.disease, 030104 developmental biology, Amacrine Cells, chemistry, biology.protein, sense organs, Neuroscience, Transcription Factors

    وصف الملف: application/pdf

  6. 6

    المصدر: Degen, W G J, Smith, J, Simmelink, B, Glass, E J, Burt, D W & Schijns, V E J C 2006, ' Molecular immunophenotyping of lungs and spleens in naive and vaccinated chickens early after pulmonary avian influenza A (H9N2) virus infection ', Vaccine, vol. 24, no. 35-36, pp. 6096-109 . https://doi.org/10.1016/j.vaccine.2006.05.027

    مصطلحات موضوعية: viruses, animal diseases, Antigens, CD/metabolism, Apoptosis, medicine.disease_cause, Influenza Vaccines/therapeutic use, Influenza A Virus, H9N2 Subtype/immunology, Immunopathology, Influenza A Virus, H9N2 Subtype, Influenza A virus, Myeloid Cells, Lung, Influenza in Birds/pathology, Antigen Presentation, B-Lymphocytes, Toll-Like Receptors, Cytokines/metabolism, Myeloid Cells/metabolism, Apoptosis/physiology, Spleen/pathology, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Up-Regulation, Infectious Diseases, Influenza Vaccines, Interferon Type I/metabolism, Lung/immunology, Interferon Type I, Cytokines, Molecular Medicine, Antibody, Spleen/immunology, Influenza in Birds/prevention & control, Influenza in Birds/immunology, Lung/pathology, Orthomyxoviridae, Immunopotentiator, Biology, Virus, Antigen, Antigens, CD, medicine, Animals, Transcription Factors/metabolism, B-Lymphocytes/metabolism, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/metabolism, Antigen Presentation/physiology, General Veterinary, General Immunology and Microbiology, Public Health, Environmental and Occupational Health, Complement System Proteins, biochemical phenomena, metabolism, and nutrition, biology.organism_classification, Virology, Immunity, Innate, Influenza A virus subtype H5N1, Influenza in Birds, Immunology, biology.protein, Toll-Like Receptors/metabolism, Complement System Proteins/metabolism, Chickens, Spleen, Transcription Factors

    وصف الملف: application/pdf

  7. 7
  8. 8
  9. 9